Literature DB >> 15486963

Cooperative effect of biliverdin and carbon monoxide on survival of mice in immune-mediated liver injury.

Gabriele Sass1, Stefan Seyfried, Miguel Parreira Soares, Kenichiro Yamashita, Elzbieta Kaczmarek, Winfried L Neuhuber, Gisa Tiegs.   

Abstract

Induction of the heme-degrading enzyme heme oxygenase-1 (HO-1) has been shown to be beneficial in terms of improvement of liver allograft survival and prevention of CD95-mediated apoptosis in the liver. In the present study, we investigated the effects of HO-1, and its products carbon monoxide (CO), biliverdin (BV), and iron/ferritin, in a mouse model of inflammatory liver damage inducible by lipopolysaccharide (LPS) in mice sensitized with the hepatocyte-specific transcription inhibitor D-galactosamine (GalN). Our results show that HO-1 induction by cobalt-protoporphyrin-IX (CoPP) reduced cytokine expression, protected mice from liver injury, and prolonged survival. While in contrast to ferritin overexpression, single administration of the CO donor methylene chloride (MC) or of BV also protected mice from liver damage, only coadministration of both HO products prolonged survival and reduced the expression of cytokines, e.g., tumor necrosis factor (TNF) and interferon gamma (IFN-gamma). In conclusion, HO-1-induced prolongation of survival, but not the protection from liver damage, seems to be dependent on down-regulation of cytokine synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486963     DOI: 10.1002/hep.20450

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

Review 2.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

Review 3.  Protective role of hemeoxygenase-1 in gastrointestinal diseases.

Authors:  Marisol Chang; Jing Xue; Vishal Sharma; Aida Habtezion
Journal:  Cell Mol Life Sci       Date:  2014-11-27       Impact factor: 9.261

4.  Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARγ and NF-κB.

Authors:  Hui Yang; Long-Feng Zhao; Zhong-Fu Zhao; Yan Wang; Jing-Jing Zhao; Li Zhang
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

5.  Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease.

Authors:  John D Belcher; Julie V Vineyard; Carol M Bruzzone; Chunsheng Chen; Joan D Beckman; Julia Nguyen; Clifford J Steer; Gregory M Vercellotti
Journal:  J Mol Med (Berl)       Date:  2010-03-23       Impact factor: 4.599

6.  Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.

Authors:  Wei-Chun Chen; Sheng-Yang Wang; Chien-Chih Chiu; Chin-Kai Tseng; Chun-Kuang Lin; Hui-Chun Wang; Jin-Ching Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

7.  Heme oxygenase-1 overexpression increases liver injury after bile duct ligation in rats.

Authors:  Matthias Froh; Lars Conzelmann; Peter Walbrun; Susanne Netter; Reiner Wiest; Michael-D Wheeler; Mark Lehnert; Takehiko Uesugi; Jurgen Scholmerich; Ronald G Thurman
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

8.  Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt.

Authors:  Barbara Wegiel; Catherine J Baty; David Gallo; Eva Csizmadia; Jeffrey R Scott; Ardavan Akhavan; Beek Y Chin; Elzbieta Kaczmarek; Jawed Alam; Fritz H Bach; Brian S Zuckerbraun; Leo E Otterbein
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

9.  Influence of heme oxygenase-1 expression on immune liver fibrosis induced by cobalt protoporphyrin in rats.

Authors:  Fei Wang; Zhi-Jun Duan; Ying-Jie Sun
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

10.  Expression of Biliverdin Reductase A in peripheral blood leukocytes is associated with treatment response in HCV-infected patients.

Authors:  Iva Subhanova; Lucie Muchova; Martin Lenicek; Hendrik J Vreman; Ondrej Luksan; Kristyna Kubickova; Miluse Kreidlova; Tomas Zima; Libor Vitek; Petr Urbanek
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.